Ondine preclinical data indicate bright hope for photodisinfection technology

VANCOUVER - Ondine Biopharma Corp. (TSX:OBP), already using lasers to activate drugs that treat gum disease, said Monday its technology shows promise against Pseudomonas aeruginosa, a dangerous hospital-acquired pathogen....More